Skip To Main Content
Yu-Ying Liao on Muck Rack

Yu-Ying Liao

As seen in: Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yu-Ying

Contact Yu-Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Rational design of G i -biased CB1 agonist with reduced side effects

|
By Jinxin Che, Linjie Li, Lin-Lin Wu, Huibing Zhang, Dan-Dan Shen, Yingjun Dong, ShaoKun Zang, Na Zhang, Hao Wang, Yan Zhang, Xiaowu Dong, Xiao-Ming Li, Yu-Ying Liao, Yu-Ying Liao, Yun-Tao Gao, Yun-Tao Gao, Jianheng Xue, Jianheng Xue, Jia-Xue Hu, Jia-Xue Hu, Meng-Ting Hu, Meng-Ting Hu, Linghua Xie, Linghua Xie
| Cell Press Verified
Keywords signaling bias CB1 cannabinoid rational design analgesic non-opioid Get full text access Log in, subscribe or purchase for full access. References 1. Thapa, D. ∙ Warne, L.N. ∙ Falasca, M. Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases Int. J. Mol. Sci. 2023; 24, 14677 2. Graczyk, M. ∙ Łukowicz, M. ∙ Dzierzanowski, T. Prospects for the Use of Cannabinoids in Psychiatric Disorders Front. Psychiatry. 2021; 12, 620073 3.
Open in Who Shared Issue with article?
See all 1 articles